{"id":"W2792237904","doi":"10.1093/cid/ciy171","title":"Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence","year":2018,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; McMaster University; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi Pasteur; Actelion Pharmaceuticals; Da Volterra; Seres Therapeutics; Sanofi; Merck; GlaxoSmithKline; European Commission; Pfizer","keywords":"Medicine; Clostridium difficile; Clostridium Infections; Clostridium; Internal medicine; Surgery; Microbiology; Antibiotics; Bacteria","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000686879,0.0002852311,0.000773029,0.0002971965,0.000222063,0.00002141933,0.0001203599,0.0002705214,0.0001429862],"category_scores_gemma":[0.008519496,0.0002668892,0.0007066362,0.0005025691,0.0003915959,0.00009777708,0.0001273914,0.0002936196,0.00003278166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004202133,"about_ca_system_score_gemma":0.0003280773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001766407,"about_ca_topic_score_gemma":0.0004255105,"domain_scores_codex":[0.9968374,0.0002658898,0.001281329,0.0007017576,0.0003928781,0.0005206893],"domain_scores_gemma":[0.9961112,0.00142461,0.0005372684,0.0005003165,0.001055426,0.0003711522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004432093,0.007127864,0.9380234,0.0004324154,0.0001302668,7.598456e-7,0.00002291729,0.000003709839,0.0002048854,0.00003325099,0.004718196,0.04487026],"study_design_scores_gemma":[0.01754887,0.02110545,0.9374204,0.0004762858,0.0006118173,0.000001297429,0.00001104815,0.0009464888,0.01648314,0.0005845302,0.004469809,0.0003408276],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935616,0.0002089733,0.0003779679,0.00005464283,0.0009254928,0.003744967,0.0008395016,0.00009335481,0.0001935323],"genre_scores_gemma":[0.9969298,0.0007003603,0.00005618103,0.00004535097,0.0008470276,0.0005755153,0.0006836871,0.00004632572,0.0001157455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04452944,"threshold_uncertainty_score":0.9999783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04982683423612503,"score_gpt":0.3943365539259603,"score_spread":0.3445097196898353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}